Skip to content

Clinical trials

Phase 3 Crohn Disease trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: Norway Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20062
20101
20111
20151
20162
20171
20181
20211
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting7
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
AbbVie2
Celgene2
Eli Lilly and Company2
GlaxoSmithKline2
UCB Pharma SA2
Abbott1
Centocor Ortho Biotech Services, L.L.C.1
Lakefront Biotherapeutics NV1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease20
Inflammatory Bowel Diseases4
Colitis, Ulcerative2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Irritable Bowel Syndrome1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.